Nielson Carrie M, Wiedrick Jack, Shen Jian, Jacobs Jon, Baker Erin S, Baraff Aaron, Piehowski Paul, Lee Christine G, Baratt Arie, Petyuk Vladislav, McWeeney Shannon, Lim Jeong Youn, Bauer Douglas C, Lane Nancy E, Cawthon Peggy M, Smith Richard D, Lapidus Jodi, Orwoll Eric S
OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
Bone and Mineral Unit, Oregon Health & Science University, Portland, OR, USA.
J Bone Miner Res. 2017 Jul;32(7):1559-1567. doi: 10.1002/jbmr.3125. Epub 2017 Apr 6.
Serum proteomics analysis may lead to the discovery of novel osteoporosis biomarkers. The Osteoporotic Fractures in Men (MrOS) study comprises men ≥65 years old in the US who have had repeated BMD measures and have been followed for incident fracture. High-throughput quantitative proteomic analysis was performed on baseline fasting serum samples from non-Hispanic white men using a multidimensional approach coupling liquid chromatography, ion-mobility separation, and mass spectrometry (LC-IMS-MS). We followed the participants for a mean of 4.6 years for changes in femoral neck bone mineral density (BMD) and for incident hip fracture. Change in BMD was determined from mixed effects regression models taking age and weight into account. Participants were categorized into three groups: BMD maintenance (no decline; estimated change ≥0 g/cm , n = 453); expected loss (estimated change 0 to 1 SD below the estimated mean change, -0.034 g/cm for femoral neck, n = 1184); and accelerated loss (estimated change ≥1 SD below mean change, n = 237). Differential abundance values of 3946 peptides were summarized by meta-analysis to determine differential abundance of each of 339 corresponding proteins for accelerated BMD loss versus maintenance. Using this meta-analytic standardized fold change at cutoffs of ≥1.1 or ≤0.9 (p < 0.10), 20 proteins were associated with accelerated BMD loss. Associations of those 20 proteins with incident hip fracture were tested using Cox proportional hazards models with age and BMI adjustment in 2473 men. Five proteins were associated with incident hip fracture (HR between 1.29 and 1.41 per SD increase in estimated protein abundance). Some proteins have been previously associated with fracture risk (eg, CD14 and SHBG), whereas others have roles in cellular senescence and aging (B2MG and TIMP1) and complement activation and innate immunity (CO7, CO9, CFAD). These findings may inform development of biomarkers for future research in bone biology and fracture prediction. © 2017 American Society for Bone and Mineral Research.
血清蛋白质组学分析可能会发现新的骨质疏松症生物标志物。男性骨质疏松性骨折(MrOS)研究纳入了美国65岁及以上的男性,这些男性接受了多次骨密度测量,并对其发生骨折的情况进行了随访。使用多维方法,将液相色谱、离子淌度分离和质谱(LC-IMS-MS)相结合,对非西班牙裔白人男性的基线空腹血清样本进行了高通量定量蛋白质组分析。我们对参与者随访了平均4.6年,以观察股骨颈骨密度(BMD)的变化以及髋部骨折的发生情况。骨密度变化通过考虑年龄和体重的混合效应回归模型来确定。参与者被分为三组:骨密度维持组(无下降;估计变化≥0 g/cm ,n = 453);预期丢失组(估计变化在估计平均变化以下0至1个标准差之间,股骨颈为-0.034 g/cm ,n = 1184);以及加速丢失组(估计变化≥平均变化以下1个标准差,n = 237)。通过荟萃分析总结了3946种肽的差异丰度值,以确定339种相应蛋白质中每种蛋白质在加速骨密度丢失与维持之间的差异丰度。使用≥1.1或≤0.9(p < 0.10)的截止值下的这种荟萃分析标准化倍数变化,20种蛋白质与加速骨密度丢失相关。在2473名男性中,使用Cox比例风险模型对这20种蛋白质与髋部骨折发生的关联进行了年龄和BMI调整后的检验。5种蛋白质与髋部骨折发生相关(估计蛋白质丰度每增加1个标准差,风险比在1.29至1.41之间)。一些蛋白质先前已与骨折风险相关(例如,CD14和SHBG),而其他蛋白质在细胞衰老和老化(B2MG和TIMP1)以及补体激活和先天免疫(CO7、CO9、CFAD)中起作用。这些发现可能为未来骨生物学研究和骨折预测的生物标志物开发提供信息。© 2017美国骨与矿物质研究学会。